Primary Care Setting Pilot Launched with NHS

DeepX Health is pleased to announce that the DermoSight Teledermatology Solution is now in use in a primary care setting, as a new pilot has been setup in a collaboration between DeepX Health Ltd and the NHS. The DermoSight platform was initiated in an existing NHS Primary Care teledermatology service following disruption and delays due to COVID-19. Within the first month of implementation benefits were realised when compared to the current system with regards to:

 

-      Ease of use and efficiency with administrative time saved

-      Consistent quality of images and no rejected consultations

-      Improvements in the recording, reporting and advice received

 

A decision to expand the service to other high output sites was made and implemented after the first 3-month trial.

October 14, 2020

DeepX Health to Present at the 8th World Congress of Teledermatology, Imaging and Artificial Intelligence for Skin Diseases

Read more

September 30, 2020

ScreenCancer Awarded Support for Diagnostic Triage Algorithm-Project

Read more

January 8, 2020

DeepX Health to participate at the 7th Annual Dermatology Summit in San Francisco

Read more

December 13, 2019

DeepX Health to present at Digital Health World Congress in London

Read more

December 3, 2019

DeepX Health participate in the DxPx Conference

Read more

December 1, 2019

ScreenCancer approved for first round of Horizon 2020 programme

Read more